Dexcom Introduces New Continuous Glucose Monitoring Technology For Aussies Living With Diabetes

The new Dexcom G7 Continuous Glucose Monitoring (CGM) system is a small, all-in-one wearable that measures and sends glucose levels in real-time to a smart device* or optional receiver
Diabetes Australia reports that diabetes is the 21st century epidemic and the biggest challenge confronting Australia’s healthcare system. More than 1.5 million Aussies live with diabetes (around 5.5% of the population) and up to 500,000 live with undiagnosed diabetes. Over 300 Aussies develop diabetes every day, equivalent to one person every five minutes¹
Dexcom G7 has the fastest sensor warmup on the market,^† with no fingerpricks^‡, and builds on the accuracy of Dexcom CGM^¶
Dexcom G6 is currently subsidised in Australia for people with Type 1 diabetes.

SYDNEY, Australia – 24^th September 2024 – DexCom Inc, leaders in glucose health for people living with diabetes, today announced that the Dexcom G7 continuous glucose monitoring (CGM) system is now available for people with diabetes age two years and older in Australia.

Dexcom G7 offers better accuracy^¶ and health outcomes^2-6and is a powerfully simple way to help people living with diabetes manage their glucose levels more confidently each day. The all-in-one wearable warms up faster than any other CGM on the market,^† sending real-time glucose readings automatically to a compatible smart device* or optional receiver, with zero fingerpricks^‡. 

“Since Dexcom G6 came to market, we’ve eliminated over 15 billion fingerpricks^††and helped improve the lives of more than 1.25 million people around the world. We’re thrilled to welcome Dexcom G7 to Australia with new features that will help Australians living with diabetes.” said Dr. Samy Saad, Sr Director, Dexcom Australia.

Dexcom G7 builds on the trusted performance of Dexcom CGM, which is clinically proven to lower HbA1c and reduce hyper- and hypoglycaemia^2-6, customisable alerts can warn of high or low glucose levels and help users spend more time in range.^2-6 Industry-leading remote monitoring and reporting capabilities also allow users to stay connected with their loved ones and care teams anytime, anywhere for peace of mind.^§

Australian supermodel, activist and entrepreneur, Bambi Northwood-Blyth** who has type 1 diabetes said she was excited to see that new G7 CGM technology was now available in Australia.

“The Dexcom G7 is now easier than ever to use and seamlessly integrates into your daily routine with customisable and predictive alerts,” said Bambi.

Dexcom is the most connected CGM in the world, ^Δ which means greater access to diabetes devices that talk to each other for better health and convenience. It is simpler than ever to seamlessly manage diabetes across various smart devices, health apps, and insulin delivery devices, including the t:slim X2 insulin pump. The Dexcom G7 is also waterproof up to 2.4 metres.^||

New features with Dexcom G7:

All-in-one discreet wearable that is 60% smaller than Dexcom G6
Indicated for wear on the back of the upper arm and abdomen for ages 2 years and older. Ages 2-6 can also wear G7 on the upper buttocks
30-minute sensor warm up, fastest of any CGM on the market^†
10-day sensor wear with an additional 12-hour grace period to replace finished sensors for a more seamless transition between sessions
Redesigned and simplified mobile app with Dexcom Clarity integration^#,††
Improved alert settings including new Quiet or Vibrate modes for enhanced discretion
Redesigned optional receiver that is smaller, with a more vibrant, easier to read display
The ability to add notes to your events
Waterproof for up to 2.4 metres when swimming, showering, or exercising^||
One click to track events like meals, insulin, activity and more
Superior accuracy^¶

Dexcom G6 features also included with Dexcom G7:

No fingerpricks^‡ or calibration
Real-time glucose readings sent automatically to a compatible display device*
Predictive alert such as the Urgent Low Soon alert
Integration with the world’s largest connected CGM ecosystem with local integrations such as t:slim X2 insulin pump, Garmin, Happy Bob, Glooko and Center Health^Δ
Remote monitoring, enabling users to share glucose data with up to 10 followers^§
24/7 technical support

For further information about the Dexcom G7 visit Dexcom.com

*Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility. †Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer. ‡If your glucose alerts and readings from Dexcom G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. ††Dexcom, data on file. ¶As compared to Dexcom G6. ||The Dexcom G7 Sensor is waterproof and may be submerged under 2.4 metres of water for up to 24 hours without failure when properly installed. §Separate Dexcom Follow app and internet connection required. Internet connectivity required for data sharing. Users should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions. **Paid Dexcom partner. ΔNot all connections are available in Australia. To learn more about insulin pump integrations and compatibility with Dexcom CGM Systems, visit dexcom.com/compatibility #Healthcare providers can register for Dexcom Clarity at clarity.dexcom.com/professional/ registration. ††An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility. Healthcare providers will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom Clarity.

References: 1 Diabetes Australia. Diabetes in Australia. Accessible at www.diabetesaustralia.com.au/about-diabetes/diabetes-in-australia. 2 Beck, RW, et al. JAMA. 2017;317(4):371-378. 3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4 Martens T, et al. JAMA. 2021;325(22):2262-2272. 5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396;3. 6 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 7 Šoupal J, et al. Diabetes Care. 2020 Jan;43(1):37-43.